Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth P Merricks

Showing results (51-60 of 54) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 54 results.
Nature Biotechnology|November 17, 2020
A long-term study of AAV gene therapy in dogs with hemophilia A identifies clonal expansions of transduced liver cellsGiang N Nguyen, John K Everett, Samita Kafle, et al.
Blood|January 17, 2012
Prolonged activity of a recombinant factor VIII-Fc fusion protein in hemophilia A mice and dogsJennifer A Dumont, Tongyao Liu, Susan C Low, et al.
Science Translational Medicine|February 21, 2024
Lipid nanoparticles and siRNA targeting plasminogen provide lasting inhibition of fibrinolysis in mouse and dog models of hemophilia AAmy W Strilchuk, Woosuk S Hur, Paul Batty, et al.
The Lancet. Haematology|June 29, 2023
Recombinant von Willebrand factor and tranexamic acid for heavy menstrual bleeding in patients with mild and moderate von Willebrand disease in the USA (VWDMin): a phase 3, open-label, randomised, crossover trialMargaret V Ragni, Scott D Rothenberger, Robert Feldman, et al.
Pageof 6

Showing results (51-60 of 54) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 54 results.
Nature Biotechnology|November 17, 2020
A long-term study of AAV gene therapy in dogs with hemophilia A identifies clonal expansions of transduced liver cellsGiang N Nguyen, John K Everett, Samita Kafle, et al.
Blood|January 17, 2012
Prolonged activity of a recombinant factor VIII-Fc fusion protein in hemophilia A mice and dogsJennifer A Dumont, Tongyao Liu, Susan C Low, et al.
Science Translational Medicine|February 21, 2024
Lipid nanoparticles and siRNA targeting plasminogen provide lasting inhibition of fibrinolysis in mouse and dog models of hemophilia AAmy W Strilchuk, Woosuk S Hur, Paul Batty, et al.
The Lancet. Haematology|June 29, 2023
Recombinant von Willebrand factor and tranexamic acid for heavy menstrual bleeding in patients with mild and moderate von Willebrand disease in the USA (VWDMin): a phase 3, open-label, randomised, crossover trialMargaret V Ragni, Scott D Rothenberger, Robert Feldman, et al.
Pageof 6